179 related articles for article (PubMed ID: 9334654)
1. Concentrations of specific epithelial growth factors in the urine of interstitial cystitis patients and controls.
Keay S; Zhang CO; Kagen DI; Hise MK; Jacobs SC; Hebel JR; Gordon D; Whitmore K; Bodison S; Warren JW
J Urol; 1997 Nov; 158(5):1983-8. PubMed ID: 9334654
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor as urine markers for interstitial cystitis.
Keay SK; Zhang CO; Shoenfelt J; Erickson DR; Whitmore K; Warren JW; Marvel R; Chai T
Urology; 2001 Jun; 57(6 Suppl 1):9-14. PubMed ID: 11378043
[TBL] [Abstract][Full Text] [Related]
3. Bladder epithelial cells from patients with interstitial cystitis produce an inhibitor of heparin-binding epidermal growth factor-like growth factor production.
Keay S; Kleinberg M; Zhang CO; Hise MK; Warren JW
J Urol; 2000 Dec; 164(6):2112-8. PubMed ID: 11061938
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor in men with interstitial cystitis versus chronic pelvic pain syndrome.
Keay S; Zhang CO; Chai T; Warren J; Koch K; Grkovic D; Colville H; Alexander R
Urology; 2004 Jan; 63(1):22-6. PubMed ID: 14751340
[TBL] [Abstract][Full Text] [Related]
5. APF, HB-EGF, and EGF biomarkers in patients with ulcerative vs. non-ulcerative interstitial cystitis.
Zhang CO; Li ZL; Kong CZ
BMC Urol; 2005 Apr; 5():7. PubMed ID: 15862132
[TBL] [Abstract][Full Text] [Related]
6. Comparison of APF activity and epithelial growth factor levels in urine from Chinese, African-American, and white American patients with interstitial cystitis.
u Zhang CO; Li ZL; Shoenfelt JL; Kong CZ; Chai TC; Erickson DR; Peters KM; Rovner ES; Keay S
Urology; 2003 May; 61(5):897-901. PubMed ID: 12735999
[TBL] [Abstract][Full Text] [Related]
7. Bladder stretch alters urinary heparin-binding epidermal growth factor and antiproliferative factor in patients with interstitial cystitis.
Chai TC; Zhang CO; Shoenfelt JL; Johnson HW; Warren JW; Keay S
J Urol; 2000 May; 163(5):1440-4. PubMed ID: 10751853
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous sacral third nerve root neurostimulation improves symptoms and normalizes urinary HB-EGF levels and antiproliferative activity in patients with interstitial cystitis.
Chai TC; Zhang C; Warren JW; Keay S
Urology; 2000 May; 55(5):643-6. PubMed ID: 10792070
[TBL] [Abstract][Full Text] [Related]
9. Decreased in vitro proliferation of bladder epithelial cells from patients with interstitial cystitis.
Keay S; Zhang CO; Shoenfelt JL; Chai TC
Urology; 2003 Jun; 61(6):1278-84. PubMed ID: 12809929
[TBL] [Abstract][Full Text] [Related]
10. Antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor: sensitive and specific urine markers for interstitial cystitis.
Keay S; Zhang CO; Marvel R; Chai T
Urology; 2001 Jun; 57(6 Suppl 1):104. PubMed ID: 11378066
[No Abstract] [Full Text] [Related]
11. EGF and HB-EGF modulate inward potassium current in human bladder urothelial cells from normal and interstitial cystitis patients.
Sun Y; Chen M; Lowentritt BH; Van Zijl PS; Koch KR; Keay S; Simard JM; Chai TC
Am J Physiol Cell Physiol; 2007 Jan; 292(1):C106-14. PubMed ID: 16837648
[TBL] [Abstract][Full Text] [Related]
12. Abnormal Akt signalling in bladder epithelial cell explants from patients with interstitial cystitis/bladder pain syndrome can be induced by antiproliferative factor treatment of normal bladder cells.
Keay SK; Zhang CO
BJU Int; 2016 Jul; 118(1):161-72. PubMed ID: 26919663
[TBL] [Abstract][Full Text] [Related]
13. Heparin-binding epidermal growth factor-like growth factor functionally antagonizes interstitial cystitis antiproliferative factor via mitogen-activated protein kinase pathway activation.
Kim J; Keay SK; Freeman MR
BJU Int; 2009 Feb; 103(4):541-6. PubMed ID: 18990151
[TBL] [Abstract][Full Text] [Related]
14. Augmented extracellular ATP signaling in bladder urothelial cells from patients with interstitial cystitis.
Sun Y; Chai TC
Am J Physiol Cell Physiol; 2006 Jan; 290(1):C27-34. PubMed ID: 16107499
[TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of candidate urine and cell markers in patients with interstitial cystitis enrolled in a randomized clinical trial of Bacillus Calmette Guerin (BCG).
Keay S; Reeder JE; Koch K; Zhang CO; Grkovic D; Peters K; Zhang Y; Kusek JW; Nyberg LM; Payne CK; Propert KJ
World J Urol; 2007 Oct; 25(5):499-504. PubMed ID: 17694391
[TBL] [Abstract][Full Text] [Related]
16. A diagnostic in vitro urine assay for interstitial cystitis.
Keay S; Zhang CO; Hise MK; Hebel JR; Jacobs SC; Gordon D; Whitmore K; Bodison S; Gordon N; Warren JW
Urology; 1998 Dec; 52(6):974-8. PubMed ID: 9836539
[TBL] [Abstract][Full Text] [Related]
17. Urinary epidermal growth factor and interleukin-6 levels in patients with painful bladder syndrome/interstitial cystitis treated with cyclosporine or pentosan polysulfate sodium.
Sairanen J; Hotakainen K; Tammela TL; Stenman UH; Ruutu M
Urology; 2008 Apr; 71(4):630-3. PubMed ID: 18387391
[TBL] [Abstract][Full Text] [Related]
18. A comparison of multiple urine markers for interstitial cystitis.
Erickson DR; Xie SX; Bhavanandan VP; Wheeler MA; Hurst RE; Demers LM; Kushner L; Keay SK
J Urol; 2002 Jun; 167(6):2461-9. PubMed ID: 11992058
[TBL] [Abstract][Full Text] [Related]
19. Chronic cystitis: excretion of epidermal growth factor (EGF)/urogastrone (URO).
Holm-Bentzen M; Lose G; Sørensen K; Jørgensen L; Nexø E
Urol Res; 1987; 15(4):203-5. PubMed ID: 3499698
[TBL] [Abstract][Full Text] [Related]
20. Changes in urine markers and symptoms after bladder distention for interstitial cystitis.
Erickson DR; Kunselman AR; Bentley CM; Peters KM; Rovner ES; Demers LM; Wheeler MA; Keay SK
J Urol; 2007 Feb; 177(2):556-60. PubMed ID: 17222633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
